HIV-2

GPTKB entity

Statements (67)
Predicate Object
gptkbp:instance_of gptkb:immunotherapy
gptkbp:advocacy important for policy change
gptkbp:affects gptkb:Cardiology
neurological disorders
chronic inflammation
immune system
gptkbp:cause gptkb:AIDS
gptkbp:civic_engagement still prevalent in many areas
gptkbp:clinical_progression slower than HIV-1
gptkbp:clinical_trial ongoing for new therapies
gptkbp:collaborations international efforts ongoing
gptkbp:community_outreach important for education
gptkbp:community_support important for mental health
gptkbp:condition opportunistic infections
certain cancers
gptkbp:diagnosis HIV test
gptkbp:discovered_by gptkb:1986
gptkbp:disease_resistance can develop
gptkbp:diseases gptkb:HBV
gptkb:HCV
gptkbp:duration lifelong
gptkbp:epidemiology less common than HIV-1
gptkbp:financial_support can be affected by diagnosis
gptkbp:frequency recommended annually
gptkbp:funding increasing over time
gptkbp:genetic_studies lower than HIV-1
gptkbp:grooming_needs can be undetectable
gptkbp:healthcare varies by region
https://www.w3.org/2000/01/rdf-schema#label HIV-2
gptkbp:is_involved_in helpful for coping
gptkbp:is_monitored_by regular viral load tests
gptkbp:is_tested_for gptkb:Western_blot
gptkb:ELISA
gptkbp:is_vulnerable_to no effective vaccine available
gptkbp:origin West Africa
gptkbp:patient_education essential for management
gptkbp:prevalence approximately 5% of HIV cases
gptkbp:prevention regular testing
condom use
Pr EP
gptkbp:public_awareness needs improvement.
gptkbp:public_health_challenge awareness
access to care
stigma
gptkbp:related_to gptkb:HIV-1
gptkbp:research_focus vaccine development
treatment strategies
gptkbp:responds_to WHO guidelines
UNAIDS initiatives
gptkbp:risk_management intravenous drug users
men who have sex with men
heterosexuals
gptkbp:social_issues important for protection
gptkbp:social_support beneficial for patients
gptkbp:symptoms flu-like symptoms
gptkbp:transmission sexual contact
blood transfusion
sharing needles
mother to child
gptkbp:treatment gptkb:immunotherapy
c ART
multiple classes of drugs
gptkbp:treatment_adherence critical for effectiveness
gptkbp:type gptkb:Retrovirus
gptkbp:type_of A, B, C, D, E, F, G, H
gptkbp:bfsParent gptkb:immunotherapy
gptkbp:bfsLayer 4